These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 12086350

  • 1. Correlates of osteoprotegerin levels in women and men.
    Khosla S, Arrighi HM, Melton LJ, Atkinson EJ, O'Fallon WM, Dunstan C, Riggs BL.
    Osteoporos Int; 2002 May; 13(5):394-9. PubMed ID: 12086350
    [Abstract] [Full Text] [Related]

  • 2. Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women.
    Rogers A, Saleh G, Hannon RA, Greenfield D, Eastell R.
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4470-5. PubMed ID: 12364420
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis.
    Franck H, Meurer T, Hofbauer LC.
    J Rheumatol; 2004 Nov; 31(11):2236-41. PubMed ID: 15517638
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Circulating osteoprotegerin and leptin levels in postmenopausal women with and without osteoporosis.
    Grigorie D, Neacşu E, Marinescu M, Popa O.
    Rom J Intern Med; 2003 Nov; 41(4):409-15. PubMed ID: 15526523
    [Abstract] [Full Text] [Related]

  • 10. Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status.
    Fahrleitner-Pammer A, Dobnig H, Piswanger-Soelkner C, Bonelli C, Dimai HP, Leb G, Obermayer-Pietsch B.
    Wien Klin Wochenschr; 2003 May 15; 115(9):291-7. PubMed ID: 12793029
    [Abstract] [Full Text] [Related]

  • 11. Circulating osteoprotegerin in women during GnRH-agonist treatment and their relationships with mineral components and biomarkers of bone turnover.
    Uemura H, Yasui T, Umino Y, Niki H, Takikawa M, Saito S, Furumoto H, Irahara M.
    Bone; 2003 Nov 15; 33(5):860-6. PubMed ID: 14623063
    [Abstract] [Full Text] [Related]

  • 12. [The relationships between changes of serum osteoprotegerin, nuclear factor-kappa B ligand receptor activator, and age, menopause, bone biochemical markers and bone mineral densities in women aged 20 - 75].
    Liu JM, Zhao HY, Ning G, Zhao YJ, Chen Y, Zhang LZ, Xu MY, Chen JL.
    Zhonghua Nei Ke Za Zhi; 2004 Jun 15; 43(6):447-50. PubMed ID: 15312444
    [Abstract] [Full Text] [Related]

  • 13. Circulating amounts of osteoprotegerin and RANK ligand: genetic influence and relationship with BMD assessed in female twins.
    Abrahamsen B, Hjelmborg JV, Kostenuik P, Stilgren LS, Kyvik K, Adamu S, Brixen K, Langdahl BL.
    Bone; 2005 Apr 15; 36(4):727-35. PubMed ID: 15781001
    [Abstract] [Full Text] [Related]

  • 14. Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle.
    Morabito N, Gaudio A, Lasco A, Atteritano M, Pizzoleo MA, Cincotta M, La Rosa M, Guarino R, Meo A, Frisina N.
    J Bone Miner Res; 2004 May 15; 19(5):722-7. PubMed ID: 15068494
    [Abstract] [Full Text] [Related]

  • 15. Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men.
    Khosla S, Atkinson EJ, Dunstan CR, O'Fallon WM.
    J Clin Endocrinol Metab; 2002 Apr 15; 87(4):1550-4. PubMed ID: 11932280
    [Abstract] [Full Text] [Related]

  • 16. The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women.
    Mezquita-Raya P, de la Higuera M, García DF, Alonso G, Ruiz-Requena ME, de Dios Luna J, Escobar-Jiménez F, Muñoz-Torres M.
    Osteoporos Int; 2005 Nov 15; 16(11):1368-74. PubMed ID: 15711777
    [Abstract] [Full Text] [Related]

  • 17. Serum levels of osteoprotegerin increase with age in a healthy adult population.
    Kudlacek S, Schneider B, Woloszczuk W, Pietschmann P, Willvonseder R, Austrian Study Group on Normative Values of Bone Metabolism.
    Bone; 2003 Jun 15; 32(6):681-6. PubMed ID: 12810175
    [Abstract] [Full Text] [Related]

  • 18. High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment.
    Amato G, Mazziotti G, Sorvillo F, Piscopo M, Lalli E, Biondi B, Iorio S, Molinari A, Giustina A, Carella C.
    Bone; 2004 Sep 15; 35(3):785-91. PubMed ID: 15336617
    [Abstract] [Full Text] [Related]

  • 19. Increased serum osteoprotegerin values in long-lived subjects: different effects of inflammation and bone metabolism.
    Mazziotti G, Amato G, Sorvillo F, Piscopo M, Rizzo MR, Lalli E, Iride L, Cioffi M, Molinari AM, Paolisso G, Carella C.
    Eur J Endocrinol; 2006 Mar 15; 154(3):373-7. PubMed ID: 16498049
    [Abstract] [Full Text] [Related]

  • 20. Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma.
    Mazziotti G, Sorvillo F, Piscopo M, Cioffi M, Pilla P, Biondi B, Iorio S, Giustina A, Amato G, Carella C.
    J Bone Miner Res; 2005 Mar 15; 20(3):480-6. PubMed ID: 15746993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.